Oral administration of nimbolide, over 12 weeks shows reduction of prostate tumour size by up to 70 per cent and decrease in tumour metastasis by up to 50 per cent
A team of international researchers led by Associate Professor Gautam Sethi from the Department of Pharmacology at the Yong Loo Lin School of Medicine at the National University of Singapore (NUS) has found that nimbolide, a bioactive terpenoid compound derived from Azadirachta indica or more commonly known as the neem plant, could reduce the size of prostate tumour by up to 70 per cent and suppress its spread or metastasis by half.
Prostate cancer is one of the most commonly diagnosed cancers worldwide. However, currently available therapies for metastatic prostate cancer are only marginally effective. Hence, there is a need for more novel treatment alternatives and options.
“Although the diverse anti-cancer effects of nimbolide have been reported in different cancer types, its potential effects on prostate cancer initiation and progression have not been demonstrated in scientific studies. In this research, we have demonstrated that nimbolide can inhibit tumour cell viability – a cellular process that directly affects the ability of a cell to proliferate, grow, divide, or repair damaged cell components – and induce programmed cell death in prostate cancer cells,” said Assoc Prof Sethi.
Nimbolide: promising effects on prostate cancer
Cell invasion and migration are key steps during tumour metastasis. The NUS-led study revealed that nimbolide can significantly suppress cell invasion and migration of prostate cancer cells, suggesting its ability to reduce tumour metastasis.
The researchers observed that upon the 12 weeks of administering nimbolide, the size of prostate cancer tumour was reduced by as much as 70 per cent and its metastasis decreased by about 50 per cent, without exhibiting any significant adverse effects.
“This is possible because a direct target of nimbolide in prostate cancer is glutathione reductase, an enzyme which is responsible for maintaining the antioxidant system that regulates the STAT3 gene in the body. The activation of the STAT3 gene has been reported to contribute to prostate tumour growth and metastasis,” explained Assoc Prof Sethi. “We have found that nimbolide can substantially inhibit STAT3 activation and thereby abrogating the growth and metastasis of prostate tumour,” he added.
The findings of the study were published in the April 2016 issue of the scientific journal Antioxidants & Redox Signaling. This work was carried out in collaboration with Professor Goh Boon Cher of Cancer Science Institute of Singapore at NUS, Professor Hui Kam Man of National Cancer Centre Singapore and Professor Ahn Kwang Seok of Kyung Hee University.
Neem – The medicinal plant
The neem plant belongs to the mahogany tree family that is originally native to India and the Indian sub-continent, but is now also commonly found in Singapore. It has been part of traditional Asian medicine for centuries and is typically used in Indian Ayurvedic medicine. Today, neem leaves and bark have been incorporated into many personal care products such as soaps, toothpaste, skincare and even dietary supplements. Neem seedlings can also be obtained from the Indian flower shops at Campbell Lane and Buffalo Road areas within Serangoon Road in Singapore.
The team is looking to embark on a genome-wide screening or to perform a large-scale study of proteins to analyse the side-effects and determine other potential molecular targets of nimbolide. They are also keen to investigate the efficacy of combinatory regimen of nimbolide and approved drugs such as docetaxel and enzalutamide for future prostate cancer therapy.
The Latest on: Prostate cancer
via Google News
The Latest on: Prostate cancer
- A miracle named Blaze: 6-year-old Moody boy gets help from Lions Club in fight against prostate cancer (with photos) on December 8, 2018 at 6:15 pm
MOODY – A miracle is taking place right here in St. Clair County, and it involves a 6-year-old boy named Blaze Powell. Powell is the son of Josh and Laurie Powell, of Moody. The miracle is how Blaze i... […]
- Cancer support group continues Toys for Tots event on December 8, 2018 at 5:11 pm
County commissioners, judges and members of the Men to Men Prostate Cancer Support Group took part in a Christmas function on Dec. 8 to support the Toys for Tots program to mingle and to give back to ... […]
- Inflammatory bowel disease linked to prostate cancer on December 7, 2018 at 10:29 am
Micrograph showing prostatic acinar adenocarcinoma (the most common form of prostate cancer) Credit: Wikipedia Men with inflammatory bowel disease have four to five times higher risk of being ... […]
- Dr. Fowke on Overcoming Racial Disparity in Prostate Cancer on December 7, 2018 at 7:32 am
Jay H. Fowke, PhD, MPH, MS, chief, Division of Epidemiology, professor of preventive medicine, University of Tennessee Health Science Center, discusses ways to overcome racial disparity in prostate ca... […]
- Prostate Cancer Linked to Inflammatory Bowel Disease on December 7, 2018 at 3:04 am
Men with inflammatory bowel disease (IBD) are at elevated risk of prostate cancer (PCa) overall as well as clinically significant PCa, new data suggest. In a retrospective study comparing 1033 men wit... […]
- AI software creates 3D model from MRI, ultrasound scans to enhance prostate cancer detection on December 6, 2018 at 1:06 pm
An artificial intelligence (AI) software system called SmartTarget—which overlays tumor information from MRI scans onto ultrasound images—may help guide surgeons in conducting biopsies and improve pro... […]
- Checkmate for prostate cancer on December 6, 2018 at 7:54 am
When prostate cancer is caught early, there are effective treatments that can provide a cure. If the cancer has spread, treatment becomes much tougher. Now a new trial is evaluating immunotherapy in p... […]
- Metastatic Prostate Cancer Target Identified for Combo Therapy on December 6, 2018 at 6:33 am
Scientists in the U.S., Spain, and Switzerland have identified a protein that could represent a new target for treatment-resistant and metastatic prostate cancer. Studies in genetically engineered mou... […]
- Revolutionary technology pinpoints biopsies to detect prostate cancer on December 5, 2018 at 5:01 pm
Micrograph showing prostatic acinar adenocarcinoma (the most common form of prostate cancer) Credit: Wikipedia Medical software developed at UCL that overlays tumour information from MRI scans ... […]
via Bing News